Endocrine disorders, such as low levels of 2,5-(OH) vitamin D and decreased levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), have been observed in patients with sarcopenia. This evidence concerns the gene IGF1 and endocrine system disorder.